未登录
分享
收藏Trends in thyroid surgery in Japan from 2014 to 2023: report on the National Clinical DatabaseOmi, Y.; Yamamoto, H.; Onoda, N.; Tomoda, C.; Okamoto, T.; Suzuki, S.; Hara, H.; Sugitani, I. 2014年至2023年日本甲状腺手术的趋势:国家临床数据库报告。Surg. Today 2025, 45, 1–7. [Google Scholar] [CrossRef]
Omi, Yoko; Yamamoto, Hiroyuki; Onoda, Naoyoshi; Tomoda, Chisato; Okamoto, Takahiro; Suzuki, Shinichi; Hara, Hisato; Sugitani, Iwao
分享
收藏
分享
收藏A Prospective Cohort Study Exploring the Effect of Lenvatinib Planned Drug Holidays in Treatment of Differentiated Thyroid Cancer
Tahara, Makoto; Takami, Hiroshi; Ito, Yasuhiro; Okamoto, Takahiro; Sugitani, Iwao; Sugino, Kiminori; Takahashi, Shunji; Takeyama, Hiroshi; Tsutsui, Hidemitsu; Hara, Hisato; Mitsuma, Ayako; Yamashita, Hiroyuki; Ohashi, Yasuo; Imai, Tsuneo
分享
收藏
分享
收藏
分享
收藏ATM Mediates pRB Function To Control DNMT1 Protein Stability and DNA Methylation
Shamma, Awad; Suzuki, Misa; Hayashi, Naoyuki; Kobayashi, Masahiko; Sasaki, Nobunari; Nishiuchi, Takumi; Doki, Yuichiro; Okamoto, Takahiro; Kohno, Susumu; Muranaka, Hayato; Kitajima, Shunsuke; Yamamoto, Ken-ichi; Takahashi, Chiaki
分享
收藏Analysis of the COLLECT Study - Efficacy and safety of lenvatinib in differentiated thyroid cancer
Iwasaki, Hiroyuki; Takami, Hiroshi; Yasuhiro, Ito; Takahiro, Okamoto; Iwao, Sugitani; Kiminori, Sugino; Shunji, Takahashi; Hiroshi, Takeyama; Hidemitsu, Tutui; Hisato, Hara; Ayako, Mitsuma; Hiroyuki, Yamashita; Yasuo, Ohashi; Takeru, Shiroiwa; Tuneo, Imai; Makoto, Tahara
分享
收藏
分享
收藏
分享
收藏
分享
收藏Synonymous but Not Silent: A Synonymous VHL Variant in Exon 2 Confers Susceptibility to Familial Pheochromocytoma and von Hippel-Lindau Disease
Flores, Shahida K.; Cheng, Ziming; Jasper, Angela M.; Natori, Keiko; Okamoto, Takahiro; Tanabe, Akiyo; Gotoh, Koro; Shibata, Hirotaka; Sakurai, Akihiro; Nakai, Takuya; Wang, Xiaojing; Zethoven, Magnus; Balachander, Shiva; Aita, Yuichi; Young, William, Jr.; Zheng, Siyuan; Takekoshi, Kazuhiro; Nakamura, Eijiro; Tothill, Richard W.; Aguiar, Ricardo C. T.; Dahia, Patricia L. M.
分享
收藏
分享
收藏SAFETY AND TOLERABILITY OF VANDETANIB IN JAPANESE PATIENTS WITH MEDULLARY THYROID CANCER: A PHASE I/II OPEN-LABEL STUDY
Uchino, Keita; Komoda, Masato; Tomomatsu, Junichi; Okamoto, Takahiro; Horiuchi, Kiyomi; Tsuji, Akihito; Ito, Yasuhiro; Todo, Takuya; Rito, Ki; Takahashi, Shunji
分享
收藏Real-time in-vivo image-guided cell-cycle perturbation to increase tumor chemosensitivity
Yano, Shuya; Tazawa, Hiroshi; Kishimoto, Hiroyuki; Kagawa, Shunsuke; Kadowaki, Yoshihiko; Ishido, Nobuhiro; Okamoto, Takahiro; Urata, Yasuo; Takehara, Kiyoto; Hoffman, Robert M.; Fujiwara, Toshiyoshi
分享
收藏A triplet combination with oxaliplatin/capecitabine/irinotecan (XELOXIRI) plus cetuximab (Cmab) as a first-line therapy in wild-type KRAS, metastatic colorectal cancer: a dose escalating study
Sato, Y.; Ohnuma, H.; Hirakawa, M.; Kikuch, S.; Takahashi, M.; Okamoto, T.; Tsuji, Y.; Okita, K.; Furuhata, T.; Takemasa, I.; Kato, J.
分享
收藏
分享
收藏
分享
收藏Thymic neuroendocrine tumour in multiple endocrine neoplasia type 1: female patients are not rare exceptions
Sakurai, Akihiro; Imai, Tsuneo; Kikumori, Toyone; Horiuchi, Kiyomi; Okamoto, Takahiro; Uchino, Shinya; Kosugi, Shinji; Suzuki, Shinichi; Suyama, Keiko; Yamazaki, Masanori; Sato, Ai
分享
收藏
分享
收藏